EU Patent Rules May Tighten Following AstraZeneca Losec Abuse Case
This article was originally published in The Pink Sheet Daily
Executive Summary
The Opinion of the Advocate General of the Court of Justice of the European Union that AstraZeneca tried to hold generic omeprazole off the market could make patent acquisitions more difficult and could impede pharmaceutical innovation.